IPHYF
Price
$1.95
Change
+$0.21 (+12.07%)
Updated
Jun 24 closing price
Capitalization
166.46M
KNBIF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Jun 24 closing price
Capitalization
6.65M
Interact to see
Advertisement

IPHYF vs KNBIF

Header iconIPHYF vs KNBIF Comparison
Open Charts IPHYF vs KNBIFBanner chart's image
Innate Pharma
Price$1.95
Change+$0.21 (+12.07%)
Volume$300
Capitalization166.46M
Kane Biotech
Price$0.04
Change-$0.00 (-0.00%)
Volume$4K
Capitalization6.65M
IPHYF vs KNBIF Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IPHYF vs. KNBIF commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHYF is a Hold and KNBIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (IPHYF: $1.95 vs. KNBIF: $0.04)
Brand notoriety: IPHYF and KNBIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHYF: 18% vs. KNBIF: 6%
Market capitalization -- IPHYF: $166.46M vs. KNBIF: $6.65M
IPHYF [@Biotechnology] is valued at $166.46M. KNBIF’s [@Biotechnology] market capitalization is $6.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHYF’s FA Score shows that 0 FA rating(s) are green whileKNBIF’s FA Score has 0 green FA rating(s).

  • IPHYF’s FA Score: 0 green, 5 red.
  • KNBIF’s FA Score: 0 green, 5 red.
According to our system of comparison, KNBIF is a better buy in the long-term than IPHYF.

Price Growth

IPHYF (@Biotechnology) experienced а +12.39% price change this week, while KNBIF (@Biotechnology) price change was -22.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

IPHYF is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
IPHYF($166M) has a higher market cap than KNBIF($6.65M). IPHYF YTD gains are higher at: -32.759 vs. KNBIF (-54.545).
IPHYFKNBIFIPHYF / KNBIF
Capitalization166M6.65M2,497%
EBITDAN/A-3.7M-
Gain YTD-32.759-54.54560%
P/E RatioN/A1.07-
RevenueN/A2.44M-
Total CashN/A494K-
Total DebtN/A2.08M-
FUNDAMENTALS RATINGS
IPHYF vs KNBIF: Fundamental Ratings
IPHYF
KNBIF
OUTLOOK RATING
1..100
4432
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
93100
PRICE GROWTH RATING
1..100
5993
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KNBIF's Valuation (34) in the null industry is somewhat better than the same rating for IPHYF (77). This means that KNBIF’s stock grew somewhat faster than IPHYF’s over the last 12 months.

KNBIF's Profit vs Risk Rating (100) in the null industry is in the same range as IPHYF (100). This means that KNBIF’s stock grew similarly to IPHYF’s over the last 12 months.

IPHYF's SMR Rating (93) in the null industry is in the same range as KNBIF (100). This means that IPHYF’s stock grew similarly to KNBIF’s over the last 12 months.

IPHYF's Price Growth Rating (59) in the null industry is somewhat better than the same rating for KNBIF (93). This means that IPHYF’s stock grew somewhat faster than KNBIF’s over the last 12 months.

KNBIF's P/E Growth Rating (94) in the null industry is in the same range as IPHYF (100). This means that KNBIF’s stock grew similarly to IPHYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VCRVX14.280.02
+0.14%
NYLI CBRE Global Infrastructure Inv Cl
GABTX23.82N/A
N/A
Gabelli Global Content & Connect AAA
BCAIX35.48N/A
N/A
Boston Common ESG Impact Intl
JGTTX39.67N/A
N/A
JPMorgan Growth Advantage R3
TAGHX31.66N/A
N/A
Transamerica US Growth R6

IPHYF and

Correlation & Price change

A.I.dvisor tells us that IPHYF and KNBIF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPHYF and KNBIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHYF
1D Price
Change %
IPHYF100%
N/A
KNBIF - IPHYF
6%
Poorly correlated
N/A
INNMF - IPHYF
6%
Poorly correlated
+61.64%
IGXT - IPHYF
6%
Poorly correlated
N/A
OTLC - IPHYF
4%
Poorly correlated
+4.44%
ISCO - IPHYF
1%
Poorly correlated
N/A
More

KNBIF and

Correlation & Price change

A.I.dvisor tells us that KNBIF and CADL have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNBIF and CADL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNBIF
1D Price
Change %
KNBIF100%
N/A
CADL - KNBIF
22%
Poorly correlated
-2.58%
LQDA - KNBIF
21%
Poorly correlated
+2.10%
SPHDF - KNBIF
20%
Poorly correlated
N/A
MMIRF - KNBIF
12%
Poorly correlated
N/A
IGXT - KNBIF
7%
Poorly correlated
N/A
More